The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:1822-1824 April 28, 2005 Number 17
NextNext

Insulin Analogues

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Hirsch, I. B.
-PubMed Citation
To the Editor: In regard to the review of insulin analogues by Hirsch (Jan. 13 issue),1 recurrent hypoglycemia is a major impediment to the achievement of good metabolic control, as defined by the Diabetes Control and Complications Trial.2 Furthermore, asymptomatic nocturnal hypoglycemic episodes are important because they reduce counterregulation and thereby increase the risk of subsequent prolonged and severe hypoglycemia, associated occasionally with coma.3 This is particularly true for small children, who have been shown to sleep through episodes of prolonged hypoglycemia. The use of regular insulin before the evening meal leads to overinsulinization during the early part of the . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.